Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Cost Plus Drugs vs Push Health

Cost Plus Drugs costs $671 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Cost Plus Drugs logo

Cost Plus Drugs

7.8
★★★★☆3.9/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Cost Plus Drugs →
VS
Push Health logo

Push Health

5.6
★★★☆☆2.8/5

Best for: semaglutide from $950/month

Visit Push Health →

If you are choosing between Cost Plus Drugs and Push Health, the first difference is cost: Cost Plus Drugs is $671 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Cost Plus Drugs leads our six-part score, 7.8 to 5.6.

Cost Plus Drugs vs Push Health price

Cost Plus Drugs is the cheaper way in: $279 a month against $950 a month at Push Health. That is $671 less each month (71% lower), or about $8,052 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Cost Plus Drugs ($279 a month vs $950 a month).

Medications and formats

Both sell semaglutide.

On format they match: each offers brand-name pens.

Where each one treats patients

Cost Plus Drugs lists 50 states, and Push Health does not publish where it ships.

Pricing

Cost Plus Drugs

Ozempic (branded, WAC + 15% + $5 pharmacy fee)Brand-name
$279/mo
semaglutide

Push Health

PreliminaryBrand-name
$950/mo
semaglutide

Ozempic / brand

What each price covers

Neither Cost Plus Drugs nor Push Health spells out what its price covers, so ask whether the visit, the drug and shipping are all in the monthly figure.

Where each one scores higher

Overall, Cost Plus Drugs scores 7.8 and Push Health 5.6 out of 10.

Cost Plus Drugs is stronger on value (10.0 vs 5.3), user experience (5.0 vs 3.0), trust & safety (5.0 vs 4.0) and accessibility (10.0 vs 5.0).

Effectiveness and support are within half a point.

How we score

Cost Plus Drugs

7.8/10

Overall

Push Health

5.6/10

Value25%

10.0A
vs
B
5.3

Effectiveness25%

9.0A
vs
B
9.0

User Experience15%

5.0A
vs
B
3.0

Trust & Safety15%

5.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.0

FDA warning letters

Neither Cost Plus Drugs nor Push Health has an FDA warning letter on record with us.

Features & Coverage

FeatureCost Plus DrugsPush Health
Starting Price✓$279/mo$950/mo
Features5 features5 features
States Available50Not disclosed
Compounded——
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Cost Plus Drugs

Cost Plus Drugs is Mark Cuban's transparent-pricing online pharmacy. It sells branded Ozempic at the wholesale acquisition cost plus a 15% markup and a flat $5 pharmacy fee, a margin formula it discloses publicly. There is no telehealth intake; this is pharmacy fulfillment only, shipping to all 50 states. Telehealth platforms that route brand-name semaglutide through similar discount channels are a separate category.

Read our full Cost Plus Drugs review →

About Push Health

A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.

Read our full Push Health review →

Pros & Cons

Cost Plus Drugs

What we like

  • Semaglutide costs $279 a month, 72% below the $990 median for brand-name semaglutide across the sellers we compare
  • Serves all 50 states
  • We found no FDA warning letters issued to Cost Plus Drugs

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Push Health

What we like

  • Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
  • We found no FDA warning letters issued to Push Health

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Cost Plus Drugs

Cost Plus Drugs wins this one, 7.8 to 5.6, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $671 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.

Choose Cost Plus Drugs if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $279 a month.

Choose Push Health if…

You want semaglutide from $950/month and an opening price near $950 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

Cost Plus Drugs vs Push Health: FAQ

Cost Plus Drugs. It starts at $279 a month; Push Health starts at $950 a month, $671 more per month.
Yes, both sell semaglutide.
Cost Plus Drugs lists 50 states; Push Health does not publish where it ships. Confirm your state before paying.
Neither says. Ask Cost Plus Drugs and Push Health for an itemized monthly total.
Cost Plus Drugs has none. Push Health has none.
No. Neither Cost Plus Drugs nor Push Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.